Markets:

Overview

News

Currencies

International

Treasuries

Neuraxis, Inc. Common Stock (NY:NRXS)

7.010 +0.170 (+2.49%)

Streaming Delayed Price Updated: 1:40 PM EDT, Apr 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Neuraxis, Inc. Common Stock

NeurAxis Inc (NYSEARCA:NRXS) Reports Q4 Revenue Beat Amid Mixed Market Reaction ↗

March 19, 2026

Via Chartmill

Neuraxis Inc (NRXS) Shows High Growth Momentum and Strong Technical Trend ↗

March 16, 2026

Via Chartmill

Which stocks are gapping on Friday? ↗

December 19, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Neuraxis Earnings Preview ↗

November 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 24, 2025

Via Benzinga

Earnings Outlook For Neuraxis ↗

August 11, 2025

Via Benzinga

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

NRXS Stock Earnings: Neuraxis Reported Results for Q2 2024 ↗

August 09, 2024

Neuraxis just reported results for the second quarter of 2024.

Via InvestorPlace

NRXS Stock Earnings: Neuraxis Reported Results for Q1 2024 ↗

May 22, 2024

Neuraxis just reported results for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 21, 2025

Via Benzinga

Top movers in Tuesday's after hours session ↗

May 20, 2025

Discover the top movers in Tuesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Gold Gains Over 1%; Amer Sports Posts Upbeat Earnings ↗

May 20, 2025

Via Benzinga

NRXS Stock Earnings: Neuraxis Misses Revenue for Q4 2023 ↗

April 16, 2024

NRXS stock results show that Neuraxis missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

SoftBank-Owned Arm, Instacart File To Go Public ↗

August 27, 2023

Via Talk Markets

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

Nasdaq Falls 100 Points; Home Depot Sales Top Views ↗

May 20, 2025

Via Benzinga

Earnings Scheduled For March 20, 2025 ↗

March 20, 2025

Via Benzinga

Earnings Scheduled For April 9, 2024 ↗

April 09, 2024

Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is projected to report quarterly loss at $0.05 per share on revenue of $198.62 million.

Via Benzinga

With Only 1.21 Million In The Trading Float, NeurAxis Stock Volatility Exposes An Opportunity, Not A Deterrent ($NRXS)

September 19, 2023

Via AB Newswire

EXCLUSIVE: NeurAxis' Nerve Field Stimulation Tech Shows Improved Quality of Life of Adolescents Patients With Irritable Bowel Syndrome ↗

September 12, 2023

NeurAxis Inc (NYSE: NRXS) announced the publication of a Prospective study evaluating the efficacy of IB-Stim in children featured in the September 2023 Frontiers in Pain Research.

Via Benzinga

CEO Spotlight: NeurAxis CEO Explains His Better Way Of Treating Pediatric IBS And FAP ($NRXS)

September 06, 2023

Via AB Newswire

Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 12, 2023

Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock.

Via Benzinga

NeurAxis Looks To Revolutionize The Treatment Of Adolescent Stomach Issues ↗

August 30, 2023

NeurAxis, Inc. (NYSEAMERICAN: NRXS) looks to revolutionize how pediatric irritable bowel syndrome (IBS) and functional abdominal pain (FAP) are treated.

Via Benzinga

EXCLUSIVE: Small MedTech Firm NeurAxis Targets $2B Market With Post-Concussion Therapy In Kids ↗

August 29, 2023

NeurAxis Inc (NYSE: NRXS) highlighted A Prospective Study on the Effect of Auricular Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients with Post-Concussion Syndrome (PCS), a...

Via Benzinga

NeurAxis Announces Positive University of Michigan IB-Stim™ Cost Effectiveness Study at ANMS 2023

August 15, 2023

From NeurAxis, Inc.

Via GlobeNewswire

Alcoholic Beverage Marketing Company LQR Debuts On Nasdaq ↗

August 13, 2023

LQR House, which provides digital marketing and branding services to the alcohol industry, went public on Thursday, raising $5 million million in its IPO. Meanwhile NeurAxis, raised $7 million in its...

Via Talk Markets

Topics Initial Public Offering

Goldman Small Cap Research Publishes New Research Report on NeurAxis, Inc.

August 11, 2023

Via ACCESSWIRE

NeurAxis Highlights Current Commercial Insurance Coverage with BCBS Massachusetts, BCBS South Carolina, BCBS Nebraska, and Quartz Wisconsin

August 10, 2023

From NeurAxis, Inc.

Via GlobeNewswire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.